Volume 13, Number 3—March 2007
Dispatch
Methicillin-susceptible, Doxycycline-resistant Staphylococcus aureus, Côte d’Ivoire
Table
Variable | PVL+DoxyR S. aureus† (n = 8) | PVL–DoxyR S. aureus‡ (n = 34) | DoxyS S. aureus§ (n = 56) | p value¶ (PVL+ vs. PVL–) | p value¶ (PVL+DoxyR vs. PVL–DoxyR) |
---|---|---|---|---|---|
Age, y | 24.3 | 25.9 | 24.5 | NS | NS |
Male (%) | 87.5 | 97.1 | 100.0 | NS | NS |
Living with health care worker (%) | 25.0 | 26.5 | 12.5 | NS | NS |
Living with children <16 y (%) | 50.0 | 61.8 | 53.6 | NS | NS |
Hospitalization within 1 year (%) | 0.0 | 17.6 | 17.8 | NS | NS |
Fight sport practice# (%) | 0.0 | 5.9 | 7.1 | NS | NS |
Previous mission in malaria-endemic area (%) | 100.0 | 91.2 | 37.5 | <0.001 | NS |
Previous mission in Côte d’Ivoire (%) | 100.0 | 88.2 | 30.4 | <0.001 | NS |
Previous doxycycline intake (%) | 100.0 | 88.2 | 32.1 | <0.001 | NS |
*PVL, Panton-Valentine leukocidin; DoxyR, doxycycline resistant; DoxyS, doxycycline susceptible; NS, not significant.
†All methicillin-susceptible S. aureus (MSSA).
‡28 MSSA and 6 methicillin-resistant S. aureus (MRSA).
§55 MSSA and 1 MRSA, all PVL-negative.
¶Fisher exact test.
#Military exercises that involve physical contact.
Page created: June 29, 2010
Page updated: June 29, 2010
Page reviewed: June 29, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.